Create a free account

US · USD

MRNA

Moderna Inc

US$188.94-1.89% (-US$3.63)
Day's range
US$186.01 – US$201.00
Day's volume
US$2.9bn
52-week range
US$22.36 – US$203.46

Follow MRNA on Fuolio

See how MRNA weighs in your net worth, what it has paid you and how far it is from your target allocation.

Create a free account

MRNA in numbers

Market cap
US$75.4bn
P/E
-23.94
P/B
11.16
Dividend yield (12m)
0.00%

MRNA price history

02/10/202501/10/2026
Compare with

MRNA risk and return

Monthly closes adjusted for splits and distributions.

Metric12 months36 months60 months
Return+595.66%+148.74%-45.27%
Volatility (annualised)165.33%111.39%93.86%
Largest drawdown-21.72%-83.10%-93.16%
Positive months7/1219/3627/60

How much did investing in MRNA return?

US$1,000.00 invested on 01/09/2021 would be worth US$500.36 today.

Value today in MRNA
US$500.36
Return over the period
-49.96%
Return per year
-12.93%
In the S&P 500
US$1,776.31

With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.

MRNA fundamentals

Valuation

  • P/E
    -23.94
  • P/B
    11.16
  • EV/EBITDA
    -24.04
  • EV/EBIT
    -22.38
  • EV/Revenue
    33.35
  • P/EBIT
    -22.72
  • P/S
    33.86
  • P/OCF
    -70.30
  • P/FCF
    -60.64
  • Earnings yield
    -4.47%
  • PEG ratio
    —
  • Earnings per share
    -US$7.89
  • Book value per share
    US$16.93

Debt

  • Net debt
    -US$1.1bn
  • Net debt/EBITDA
    —
  • Net debt/Equity
    -0.17
  • Debt/Equity
    0.09
  • Current ratio
    2.29
  • Quick ratio
    2.18
  • Cash ratio
    0.68

Efficiency

  • Gross margin
    23.38%
  • EBITDA margin
    -138.73%
  • Operating margin
    -149.01%
  • Net margin
    -141.43%
  • Asset turnover
    0.20

Profitability

  • ROE
    -46.61%
  • ROA
    -28.75%
  • ROIC
    -58.98%
  • Payout
    —

Growth

  • Revenue CAGR (5 years)
    -20.51%
  • Earnings CAGR (5 years)
    —
  • Revenue growth (year)
    —
  • Earnings growth (year)
    —
  • Revenue growth (quarter)
    —
  • Earnings growth (quarter)
    —

MRNA indicators by year

Multiples at each year's closing price; margins and returns from that year's accounts.

Indicator20252024202320222021202020192018
P/E-4.13-4.50-8.068.308.39-55.91-14.03—
P/B1.351.472.743.637.2316.316.14—
EV/EBITDA———7.107.56———
Earnings per share-US$7.15-US$9.23-US$12.34US$21.64US$30.29-US$1.87-US$1.39-US$1.17
Book value per shareUS$21.90US$28.25US$36.26US$49.50US$35.11US$6.41US$3.19US$4.65
ROE-32.62%-32.67%-34.03%43.73%86.26%-29.17%-43.74%-25.15%
ROIC-46.26%-43.40%-30.60%43.02%86.34%-29.79%-46.38%-27.01%
Gross margin55.35%54.76%31.47%71.88%85.83%99.00%100.00%100.00%
EBITDA margin-147.27%-116.19%-52.89%50.71%73.24%-91.16%-855.35%-287.56%
Net margin-145.16%-110.04%-68.84%43.41%66.06%-93.03%-853.69%-284.84%

MRNA financial statements

Line202520242023202220212020
Net revenueUS$1.9bnUS$3.2bnUS$6.8bnUS$19.3bnUS$18.5bnUS$803m
Cost of sales-US$868m-US$1.5bn-US$4.7bn-US$5.4bn-US$2.6bn-US$8m
Gross profitUS$1.1bnUS$1.8bnUS$2.2bnUS$13.8bnUS$15.9bnUS$795m
EBITDA-US$2.9bn-US$3.8bn-US$3.6bnUS$9.8bnUS$13.5bn-US$732m
EBIT-US$3.1bn-US$3.9bn-US$4.2bnUS$9.4bnUS$13.3bn-US$763m
Net finance result——————
Profit before tax-US$2.8bn-US$3.6bn-US$3.9bnUS$9.6bnUS$13.3bn-US$744m
Income tax-US$54mUS$46m-US$772m-US$1.2bn-US$1.1bn-US$3m
Net income-US$2.8bn-US$3.6bn-US$4.7bnUS$8.4bnUS$12.2bn-US$747m

Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.

Does MRNA pay dividends?

MRNA has no distributions on record.

About Moderna

Sector
Manufacturing

Questions about MRNA

How much is MRNA today?

MRNA is at US$188.94 (-1.89% on the day), last traded on 01/10/2026.

What are the P/E and P/B of MRNA?

MRNA trades at a P/E of -23.94 and a P/B of 11.16.

How much did MRNA return in 12 months?

MRNA returned 595.66% in 12 months, with annualised volatility of 165.33% and a largest drawdown of -21.72%.